- Home
- OVID vs ITRM Comparison
OVID vs ITRM Comparison
Compare OVID & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- ITRM
- Stock Information
- Founded
- OVID 2014
- ITRM 2015
- Country
- OVID United States
- ITRM Ireland
- Employees
- OVID N/A
- ITRM N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- OVID Health Care
- ITRM Health Care
- Exchange
- OVID Nasdaq
- ITRM Nasdaq
- Market Cap
- OVID 47.1M
- ITRM N/A
- IPO Year
- OVID 2017
- ITRM 2018
- Fundamental
- Price
- OVID $0.31
- ITRM $1.25
- Analyst Decision
- OVID Strong Buy
- ITRM Strong Buy
- Analyst Count
- OVID 6
- ITRM 1
- Target Price
- OVID $3.03
- ITRM $5.00
- AVG Volume (30 Days)
- OVID 343.6K
- ITRM 267.7K
- Earning Date
- OVID 03-11-2025
- ITRM 05-12-2025
- Dividend Yield
- OVID N/A
- ITRM N/A
- EPS Growth
- OVID N/A
- ITRM N/A
- EPS
- OVID N/A
- ITRM N/A
- Revenue
- OVID $566,000.00
- ITRM N/A
- Revenue This Year
- OVID N/A
- ITRM N/A
- Revenue Next Year
- OVID $36.11
- ITRM $160.88
- P/E Ratio
- OVID N/A
- ITRM N/A
- Revenue Growth
- OVID 44.39
- ITRM N/A
- 52 Week Low
- OVID $0.31
- ITRM $0.81
- 52 Week High
- OVID $3.45
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- OVID 22.55
- ITRM 33.48
- Support Level
- OVID $0.42
- ITRM $1.37
- Resistance Level
- OVID $0.48
- ITRM $1.50
- Average True Range (ATR)
- OVID 0.05
- ITRM 0.07
- MACD
- OVID -0.01
- ITRM -0.01
- Stochastic Oscillator
- OVID 1.73
- ITRM 13.33
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.